Display options
Share it on

PLoS One. 2012;7(4):e34807. doi: 10.1371/journal.pone.0034807. Epub 2012 Apr 17.

Diabetic neuropathy and axon reflex-mediated neurogenic vasodilatation in type 1 diabetes.

PloS one

Maryam Nabavi Nouri, Ausma Ahmed, Vera Bril, Andrej Orszag, Eduardo Ng, Patti Nwe, Bruce A Perkins

Affiliations

  1. Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.

PMID: 22529938 PMCID: PMC3328500 DOI: 10.1371/journal.pone.0034807

Abstract

OBJECTIVE: Axon reflex-mediated neurogenic vasodilatation in response to cutaneous heating may reflect early, pre-clinical small fibre dysfunction. We aimed to evaluate the distribution of the vascular flare area measured by laser doppler imaging ("LDI(FLARE) area") in type 1 diabetes and in healthy volunteers.

RESEARCH AND METHODS: Concurrent with clinical and electrophysiological examination to classify diabetic sensorimotor polyneuropathy (DSP), LDI(FLARE) area (cm(2)) was determined in 89 type 1 diabetes subjects matched to 64 healthy volunteers. We examined the association and diagnostic performance of LDI with clinical and subclinical measures of DSP and its severity.

RESULTS: Compared to the 64 healthy volunteers, the 56 diabetes controls without DSP had significantly lower LDI(FLARE) area (p = 0.006). The 33 diabetes cases with DSP had substantially lower LDI(FLARE) area as compared to controls without DSP (p = 0.002). There was considerable overlap in LDI(FLARE) area between all groups such that the ROC curve had an AUC of 0.72 and optimal sensitivity of 70% for the detection of clinical DSP. Use of a subclinical definition for DSP, according to subclinical sural nerve impairment, was associated with improved AUC of 0.75 and sensitivity of 79%. In multivariate analysis higher HbA1c and body mass index had independent associations with smaller LDI(FLARE) area.

CONCLUSIONS: Axon reflex-mediated neurogenic vasodilatation in response to cutaneous heating is a biomarker of early nerve dysfunction in DSP. Its independent association with glycemic exposure in diabetes subjects and both glycemic exposure and BMI in healthy volunteers highlights the existence of small-fibre dysfunction in the natural history of DSP.

References

  1. Neurologist. 2008 Jan;14(1):23-9 - PubMed
  2. J Vis Exp. 2011 Jan 03;(47): - PubMed
  3. Neurology. 2003 Jan 14;60(1):108-11 - PubMed
  4. Diabetes Care. 2004 Dec;27(12):2930-5 - PubMed
  5. Diabetes Care. 2004 Jul;27(7):1674-9 - PubMed
  6. Diabetes Care. 2007 Dec;30(12):3058-62 - PubMed
  7. Diabetes Care. 2009 Mar;32(3):451-5 - PubMed
  8. Muscle Nerve. 2005 Nov;32(5):619-25 - PubMed
  9. Cornea. 2006 Aug;25(7):761-8 - PubMed
  10. Intern Med. 2002 Dec;41(12):1079-80 - PubMed
  11. Diabetes. 1989 Nov;38(11):1456-61 - PubMed
  12. Clin Neurophysiol. 2003 Jul;114(7):1167-75 - PubMed
  13. Muscle Nerve. 2009 Dec;40(6):985-91 - PubMed
  14. Neurology. 2005 Jan 25;64(2):199-207 - PubMed
  15. Diabetes Care. 2010 Jul;33(7):1549-54 - PubMed
  16. Diabetes Care. 1992 Aug;15(8):1092-4 - PubMed
  17. Diabetologia. 1996 Nov;39(11):1377-84 - PubMed
  18. Diabetes Care. 2009 Jul;32(7):1327-34 - PubMed
  19. J Neurophysiol. 1999 Nov;82(5):2602-11 - PubMed
  20. Neuroreport. 2000 Feb 28;11(3):645-8 - PubMed
  21. Diabetes Care. 1999 Apr;22(4):593-7 - PubMed
  22. Diabetes Care. 2010 Jan;33(1):174-6 - PubMed
  23. Neurology. 2009 Jan 13;72(2):177-84 - PubMed
  24. Muscle Nerve. 1997 Feb;20(2):198-204 - PubMed
  25. Diabetes Care. 2002 Nov;25(11):2048-52 - PubMed
  26. Diabetes Res Clin Pract. 2001 Nov;54(2):115-28 - PubMed
  27. J Neurol Neurosurg Psychiatry. 2006 Aug;77(8):927-32 - PubMed
  28. J Pain. 2010 Apr;11(4):360-8 - PubMed
  29. Diabetes Care. 2001 Feb;24(2):250-6 - PubMed
  30. Diabetes Res Clin Pract. 2011 May;92(2):280-7 - PubMed
  31. Lancet. 2005 Oct 15-21;366(9494):1340-3 - PubMed
  32. Diabetes. 2007 Aug;56(8):2148-54 - PubMed
  33. Diabetes. 1990 Sep;39(9):1116-24 - PubMed
  34. Diabetes Care. 2005 Apr;28(4):956-62 - PubMed

MeSH terms

Publication Types